Raymond James & Associates’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$155K Buy
+10,586
New +$155K ﹤0.01% 3667